Piperacetazine

CHEMBL1584 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
410.6 g/mol
LogP
4.0
Phase
4

Piperacetazine is a typical antipsychotic of the phenothiazine class that acts primarily through dopamine D2 receptor blockade in the mesolimbic and nigrostriatal pathways to reduce psychotic symptoms. It was used in the management of schizophrenia and other psychotic disorders, though it has largely been superseded by newer antipsychotic agents.

분자량

410.6000 g/mol

LogP

4.00

TPSA

69.10 Ų

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2

InChI

InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3

Molecular Formula

C24H30N2O2S

HBD / HBA

1 / 5

회전 가능 결합

7

무거운 원자

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Piperacetazine is a typical antipsychotic of the phenothiazine class that acts primarily through dopamine D2 receptor blockade in the mesolimbic and nigrostriatal pathways to reduce psychotic symptoms. It was used in the management of schizophrenia and other psychotic disorders, though it has largely been superseded by newer antipsychotic agents.

Yes, Piperacetazine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1584. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 19675. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.